ALKS - Alkermes Plc - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALKS is currently covered by 13 analysts with an average price target of $35.91. This is a potential upside of $5.53 (18.2%) from yesterday's end of day stock price of $30.38.

Alkermes Plc's activity chart (see below) currently has 303 price targets and 233 ratings on display. The stock rating distribution of ALKS is 39.53% HOLD, 55.81% BUY and 4.65% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 74.21% with an average time for these price targets to be met of 228.27 days.

Highest price target for ALKS is $46, Lowest price target is $26, average price target is $36.09.

Most recent stock forecast was given by ASHWANI VERMA from UBS on 04-Mar-2025. First documented stock forecast 17-Oct-2013.

Split History since 2000:

5/15/00 2 for 1

Currently out of the existing stock ratings of ALKS, 17 are a HOLD (39.53%), 24 are a BUY (55.81%), 2 are a SELL (4.65%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

$38

$6.22 (19.57%)

$25

2 months 5 days ago
(04-Mar-2025)

2/3 (66.67%)

$3.89 (11.40%)

86

Buy

$32

$0.22 (0.69%)

$30

2 months 25 days ago
(14-Feb-2025)

13/18 (72.22%)

$-3.89 (-10.84%)

631

Hold

$46

$14.22 (44.75%)

$37

2 months 26 days ago
(13-Feb-2025)

19/23 (82.61%)

$10 (27.78%)

295

Buy

$40

$8.22 (25.87%)

$35

5 months 26 days ago
(13-Nov-2024)

4/6 (66.67%)

$10.76 (36.80%)

699

Buy

$36

$4.22 (13.28%)

$25

6 months 4 days ago
(05-Nov-2024)

20/27 (74.07%)

$7.63 (26.89%)

141

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALKS (Alkermes Plc) average time for price targets to be met?

On average it took 228.27 days on average for the stock forecasts to be realized with a an average price target met ratio 74.21

Which analyst has the current highest performing score on ALKS (Alkermes Plc) with a proven track record?

MICHAEL SCHMIDT

Which analyst has the most public recommendations on ALKS (Alkermes Plc)?

Michael Schmidt works at GUGGENHEIM and has 5 price targets and 6 ratings on ALKS

Which analyst is the currently most bullish on ALKS (Alkermes Plc)?

Jonathan Eckard with highest potential upside - $34.22

Which analyst is the currently most reserved on ALKS (Alkermes Plc)?

Terence Flynn with lowest potential downside - -$15.78

Alkermes Plc in the News

Alkermes' Q1 Earnings and Revenues Fall Short of Estimates

Alkermes plc ALKS reported earnings from continuing operations of 13 cents per share for first-quarter 2025, which missed the Zacks Consensus Estimate of 28 cents. The company had reported earnings of 21 cents per share in the year-ago quarter. Alkermes’ total revenues of $306.5 million in the first quarter decreased 12.5% from the year-ago quarter’s...

Alkermes PLC (ALKS) Q1 2025 Earnings Call Highlights: Strong Proprietary Product Growth and ...

Total Revenue: $306.5 million for Q1 2025. Net Sales from Proprietary Products: $244.5 million, reflecting 5% year-over-year growth. Vivitrol Net Sales: $101 million for Q1 2025. Aristada Net Sales: $73.5 million for Q1 2025. Lybalvi Net Sales: $70 million, with 23% year-over-year growth. Manufacturing and Royalty Revenues: $62 million for Q1 2025. Cost of Goods...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?